Prospective Evaluation of Rate of Fusion with Augment Injectable Bone Graft

Category: Hindfoot; Basic Sciences/Biologics Introduction/Purpose: Augment ® Bone Graft is a mixture of rhPDGF-BB, beta-TCP and bovine collagen which has received FDA approval for use as a substitute for autografts during hindfoot and/or ankle arthrodesis. Although a recent meta analysis demonstrate...

Full description

Bibliographic Details
Main Authors: Philip J. Shaheen MD, Jacob Priester MD, BS, Eric Giza MD, Christopher D. Kreulen MD, MS
Format: Article
Language:English
Published: SAGE Publishing 2023-12-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/2473011423S00387